Mb, Levis & Associates, LLC Abbott Laboratories Transaction History
Mb, Levis & Associates, LLC
- $215 Billion
- Q1 2025
A detailed history of Mb, Levis & Associates, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Mb, Levis & Associates, LLC holds 17,253 shares of ABT stock, worth $2.29 Million. This represents 1.06% of its overall portfolio holdings.
Number of Shares
17,253
Previous 17,295
0.24%
Holding current value
$2.29 Million
Previous $1.96 Billion
16.99%
% of portfolio
1.06%
Previous 0.98%
Shares
10 transactions
Others Institutions Holding ABT
# of Institutions
3,485Shares Held
1.34BCall Options Held
10.6MPut Options Held
8.75M-
Vanguard Group Inc Valley Forge, PA169MShares$22.4 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.2 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$9.01 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.17 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $232B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...